Barely Significant
← all excerpts

Add-on iguratimod or tacrolimus in methotrexate in patients with rheumatoid arthritis not achieving remission with methotrexate: a retrospective propensity score-matched study.

BMC Rheumatol · 2025 · PMC12859856 · PMID 41469744

1
hedged sentence
closest p
boldest claim

The sentences

While the TAC group showed numerical trends toward greater improvements in SDAI, CDAI, and CRP, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.